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ABSTRACT 
The risks incurred from increased exposure to UVA I1 
(320-340 nm) (i.e. during sunscreen use and extended 
outdoor exposure, tanning parlors) are not well under- 
stood. Therefore, we explored the effects of UVA II on 
skin immune responses in humans. After a single local 
exposure (4 minimum erythemal dose [MED]) using a 
xenon arc lamp filtered with a narrow bandpass filter 
(335 2 5 nm full width at half maximum), individuals 
were contact-sensitized with dinitrochlorobenzene 
(DNCB) through a UVA I1 exposure site or through nor- 
mal skin. UVA 11 induced a marked decrease in the mag- 
nitude of skin immune responses (P < 0.OOOl). The UVA 
I1 group had only 29% successful sensitizations, as com- 
pared to 83% in the control group. The percentage of 
individuals who remained tolerant to DNCB after two 
sensitizations was 23.6% for the UVA 11-exposed group, 
as compared to 3.8% in the controls (P = 0.006). UVA 
11 also uniquely altered the type of antigen-presenting 
cells present in the epidermis. Human leukocyte antigen 
(HLA)-DR' cells in control epidermal cell suspensions 
(C-EC) comprised a single, homogeneous population of 
Langerhans cells (LC) with the phenotype: CDlah' DRmid 
CDllb- CD36- (1.5 2 0.3% of EC). UVA 11 irradiation 
reduced the number of such LC to 0.6 2 0.2% of EC. 
Although cells expressing the macrophage phenotype: 
CDla- DRhi CDllb' CD36' were increased in UVA I1 
skin, relative to C-EC, these comprised only 10.1 2 6.1% 
of the DR+ cells, which is less than that after UVB ex- 
posure. Also distinct from UVB, a third population was 
found in UVA 11-EC, which exhibited a novel phenotype: 
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CDla' DR' CD36' CDllb'; these comprised 11.1 2 
6.9% of the DR' UVA 11-EC. 
In conclusion, despite the above differences in infil- 
trating DR' cells, both UVB and UVA I1 reduce the 
skin's ability to support contact sensitization, induce ac- 
tive suppression (tolerance) and induce a reduction in 
LC. 
INTRODUCTION 
In addition to the well-publicized increases in UVB due to 
ozone depletion, the potential for greater exposure to UVA 
is also increasing. The major deleterious effects of UVB 
wavelengths are well established. Clinically, these include 
the discomforts of sunburn, accelerated aging and wrinkling 
of chronically exposed skin, and the well-established rela- 
tionships between UVB exposure and skin cancer. Immu- 
nologically, UVB exposure creates an immunosuppressed 
state in the host that increases susceptibility to skin cancers 
( 1 4 )  and microbes (5-7), which appears due to alterations 
in presentation of the antigen to antigen-specific T lympho- 
cytes (2,8). These phenomena are nicely modeled by the 
contract sensitivity model of inducing antigen-specific de- 
layed-type hypersensitivity, in which unresponsiveness and 
tolerance to antigens initially presented through UVB-ex- 
posed skin of both mice (9,lO) and humans (1 1,12) is dem- 
onstrated to be due to T cells that block subsequent attempts 
to immunize through UV-irradiated skin (tolerance) 
(8,13,14). Mechanistically UVB depletes epidermal Langer- 
hans cells (LC)? from the epidermis (15,16); however, the 
wavelength dependence of LC alteration and the wavelength 
dependence of contact sensitivity suppression are not the 
tAbbreviurions: APC, allophycocyanin; DNCB, dinitrochloroben- 
zene; DPCP, diphenylcyclopropenone; EC, epidermal cells; EMA, 
ethidium monoazide; FITC, fluorescein isothiocyanate; HLA, hu- 
man leukocyte antigen: LC, Langerhans cells; MED, minimal er- 
ythemal dose; PBS, phosphate-buffered saline; UVA I, 340400  
nm radiation; UVA 11, 320-340 nm radiation. 
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same: UVA I (340400 nm) depletes LC in mice and hu- 
mans (16-1 8) but does not induce distant immunosuppres- 
sion, in contrast to UVB (19-21). and does not create a 
distant (systemic) immunological susceptibility to UV skin 
cancer (22). Whereas UVB induces epidermal infiltration of 
neutrophils (23) and immunosuppressive macrophages (24- 
28). UVA I is unable to induce leukocyte infiltration (29) 
and allows a rapid recovery of LC function (30). Other bi- 
ological effects of long-wave UVA (UVA I) appear to be 
distinct in many ways from those of UVB (31). These effects 
include: 1000-fold less biological activity, less carcinogenic 
potential (32) and differential effects on lipid mediators (33- 
35), cytokine induction (36,27), DNA (38) and proteases 
(39,40). 
The effects of the UVA I1 (320-340 nm) wavelengths are 
less well studied and somewhat controversial (38). However, 
the frequency and intensity of exposure is increasing due to 
a number of factors. Many people are increasing their use 
of sunscreen products. This may result in an increase in their 
exposure to UVA, from 1) incomplete UVA protection by 
sunscreens designed to protect against UVB and from 2) 
longer exposure times allowed by the sunscreen before vis- 
ible sunburn is apparent. Others increase their exposure to 
UVA by frequenting tanning parlors where UVA I1 radiation 
is a major component of the output of the lamps used. Many 
sun-sensitive people do both, in search of a “safe” means 
of obtaining a cosmetically attractive “healthy tan.” Fur- 
thermore, stratospheric ozone performs a filtering function 
on solar UVA 11, albeit not to the same degree as to UVB 
and UVC, and ozone depletion may increase its irradiance 
The purpose of this study was to determine whether UVA 
I1 differs from UVB in its ability to suppress epicutaneous 
immunization with dinitrochlorobenzene (DNCB) through 
exposed skin of humans, to determine whether UVA I1 is 
able to induce tolerance to subsequent DNCB immunizations 
on normal skin, and to determine whether UVA I1 is able to 
induce the influx of CDla- CD36’ DR’ epidermal macro- 
phages such as those that infiltrate epidermis following UVB 
irradiation of human skin. 
(41). 
MATERIALS AND METHODS 
Volunteers. Paid volunteers were recruited, were screened for skin 
type and health status, gave signed informed consent and were treat- 
ed using Institutional Review Board approved procedures forms and 
protocols. Subjects were randomly assigned to control and to UVA- 
irradiated groups. The selected volunteers were limited to skin types 
I, I1 or Ill, were free from chronic disease and were not currently 
using medication. 
UVA If light source. Ultraviolet A I I  radiation was supplied by a 
5000 W xenon arc lamp (Optical Radiation Corporation, Azusa, CA) 
mounted in a modified Kratos lamp housing fitted with an IR-ab- 
sorbing H,O filter (Spectral Energy Corporation, Westwood, NJ), a 
UV-reflecting dichroic mirror (-270-520 nm) and a narrow band- 
pass filter (335 nm, 10 ? 2 nm full width, half maximum) (Andover 
Corporation. Salem, NH). Lamp output was monitored before and 
after each exposure, using an International Light IL-435 photother- 
apy radiometer fitted with a UVA filter on an SED 1240 detector 
(International Light, Inc., Newburyport, MA). Spectral output of the 
narrow bandpass filters used was checked using a Kratos 250 mm 
grating monochromator (Spectral Energy Corporation, Westwood, 
NJ), using an IL-770 radiometer fitted with an SED 400 detector, 
QNDS (broad spectrum) filter and W diffuser. 
Ultraviolet B was provided by a bank of FS-20 sunlamps with 
output as previously described (12.25.42). 
The UVA I1 source stability was monitored with an IL-435 pho- 
totherapy radiometer fitted with an SED 240 detector fitted with a 
UVA filter and wide angle window. The UVB source was monitored 
with an IL-435 phototherapy radiometer fitted with an SED 240 
detector fitted with a UVB filter and wide angle window. 
Irradiation. The minimal erythema1 dose (MED) for UVA II was 
determined for each volunteer to enable delivery of biologically 
equivalent doses of UVR. The MED were determined by giving each 
subject a sequence of four exposures of increasing intensities, 10, 
20, 30 and 40 J/cm2. Four MED of UVA 11 were subsequently ad- 
ministered to an area of 2.5 cm by 5 cm on the left buttock of each 
volunteer in the irradiated group. 
Sensitization. On the third day after irradiation, a 12 mm Finn 
chamber containing 48 pL  (30 pg) of 0.0625% DNCB in acetone 
was placed on the irradiation site (left buttock). A similar chamber 
containing 48 pL (22.5 pg) of 0.0469% diphenylcyclopropenone 
(DPCP) in acetone was placed on the unirradiated right buttock as 
a control for unimpaired immune response and as a control for dis- 
tant suppression. An equal number of unirradiated control volunteers 
was also sensitized on similar sites. The chambers remained in place 
on the skin for 48 h(121). 
Challenge. Two to three weeks after sensitization, the skin fold 
thickness of the challenge sites was measured with an engineers’ 
spring-loaded micrometer (Mitutoyo Manufacturing, Tokyo) and 
Finn chambers containing reduced quantities of the sensitizing 
chemicals were applied to the inner upper arms of each volunteer 
and left in place for 6 h, as modified from the method of Friedmann 
et al. (43). On the right arm, one chamber contained vehicle control 
and four contained increasing concentrations of DNCB (3.125 pg, 
6.126 pg, 8.8 pg and 12.5 pg). An additional four chambers con- 
taining the control chemical DPCP (0.390 pg, 0.781 pg, 1.56 pg 
and 3.125 pg) were placed on the left arm (12). 
Two days later, the intensity of the hypersensitivity response was 
determined by again measuring the skin fold thickness of the chal- 
lenge sites. The difference between the before challenge and after 
challenge measurements was expressed as increase in skin thickness 
in mm. A visual evaluation of the response was also recorded using 
the National Allergic Contact Dermatitis Group (NACDG) scale 
(12). 
Epidermal cell (EC) isolation. For evaluation of UVA 11 effects 
on epidermal antigen-presenting cell population density and surface 
antigen profile, volunteers were irradiated with 4 MED UVA II as 
described above. Three days following irradiation, UVA II-irradiated 
skin and unirradiated control skin samples were obtained from each 
volunteer by keratome biopsy and EC suspensions were prepared as 
previously described (42). Briefly, the epidermis was separated from 
the dermis by overnight incubation with Dispase” (Collaborative 
Research, Waltham, MA) and EC suspensions obtained by incuba- 
tion for 10 min in 0.125% trypsin in phosphate-buffered saline 
(PBS). The action of the trypsin was stopped by transfer of the 
epidermis to PBS containing 20% fetal calf serum plus 0.05% DNa- 
se to remove DNA released from damaged cells. The tissues were 
gently agitated to disperse the EC and cell clumps were removed by 
filtration through 112 mesh NYTEX@ nylon screen (42). 
Staining to  identib EC phenorypes. Aliquots of EC suspensions 
were preincubated for 30 min at 4°C with mouse IgGI, mouse IgG2 
(Sigma) and normal human AB serum, at 20 p L  each per lo6 cells. 
The cells were then stained with specific antibodies directly conju- 
gated to the fluorochromes (or to biotin in the case where the strep- 
tavidin allophycocyanin [APC] secondary fluorochrome was used) 
at 2 pg/lOb cells for 45 min at 4°C. washed three times and the cells 
incubated with APC for 30 min. After one wash, ethidium mono- 
azide (EMA) was added to each sample (to identify nonviable cells), 
incubated under fluorescent lamps for 10 min (23,44), washed again 
and fixed in formaldehyde for flow cytometric analysis. Epidermal 
cell phenotypes were identified by four-color flow cytometry (42). 
Viable EC (EMA negative) were selected based on low EMA 
intensity (lack of uptake of EMA by viable cells). The specific an- 
tibodies used for obtaining EC subpopulations were: PE anti-human 
leukocyte antigen (HLA)-DR (Ig2a isotype) and PE anti-CD1 1 b 
(IgG1 isotype) both from Becton Dickenson, San Jose, CA. The PE 
anti-CDla (T6 RDI) from Coulter, Hialeah, FL; fluorescein isothio- 
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Figure 1. Four MED UVA I1 (335 2 5 nm) reduces the mean 
response to DNCB sensitization in humans to a level equal to that 
produced by a 4 MED UVB exposure. A single exposure of either 
UVA 11 or UVB given 3 days prior to sensitization significantly 
reduces the response to DNCB sensitization as measured by the 
mean increase in skin thickness (mm) at challenge (y axis). Unir- 
radiated controls, mean = 0.284 t 0.28 mm, n = 88; UVA 11-ir- 
radiated, mean = 0.77 2 0.17 mm, n = 24; and UVB-irradiated, 
mean = 1.23 ? 0.23 mm, n = 34. For UVA 11-irradiated subjects 
vs control subjects, P = O.ooOOI4; for UVA 11-irradiated vs UVB- 
irradiated are not significantly different, P = 0.144; for UVB-irra- 
diated vs control, P = O.OOO113. 
cyanate (FITC) anti-CdI Ib (AMAC, Westbrook, ME), FITC anti- 
CDla (OKT6). FITC anti-CD36 (OKM5) (both, Ortho, Raritan, NJ), 
and biotinylated CDI Ic (Sigma, St. Louis, MO) were all of IgGl 
isotype. Biotinylated anti-HLA-DR, with isotype IgG2a. was from 
Becton Dickenson. The HLA-DR' cells were selected from among 
the viable cells based upon intensity of APC staining. Displaying 
the HLA-DR' population of cells on histograms whose axes dis- 
played the intensity of staining for a pair of the other antigens al- 
lowed identification of cell populations that were single positive, 
double positive or triple positive for the antigens being analyzed. 
RESULTS 
Effects of UVA II radiation on human sensitization to 
DNCB 
Like UVB, a single 4 MED dose of UVA 11, given 3 days 
prior to sensitization with DNCB, strongly suppresses the 
contact sensitivity response in humans, as measured by the 
mean increase in skin fold thickness (edema) in mm upon 
DNCB challenge (Fig. 1).  The unirradiated control subjects 
were pooled from concurrent and historical controls for com- 
parison to both the W B  and UVA I1 groups. The increase 
in mean thickness was 2.84 2 0.28 mm, n = 88, for the 
unirradiated control group. The mean thickness increase for 
the UVA 11-irradiated subjects was 0.775 2 0.17 mm, n = 
24, a significant reduction (P = O.oooO14) upon comparison 
to the unirradiated controls. As previously described (12), 
the mean increase in skin fold thickness for the UVB-irra- 
diated subjects, 1.23 2 0.23 mm, n = 34, was also signifi- 
cantly different from the controls, P = 0.00013. The differ- 
ence between the UVA 11-irradiated group and the UVB 
group was not significant, P = 0.14. Thus, at 4 MED, UVA 
I1 is as effective as UVB in inducing suppression of the 
contact hypersensitivity response to DNCB. 


















Figure 2. Scattergram reveals relatively homogenous reduction of 
DNCB response in human subjects sensitized on UVA 11-exposed 
skin. A single exposure of UVA I1 (335 2 5 nm) given 3 days prior 
to sensitization significantly reduces the response to DNCB sensi- 
tization as measured by the mean increase in skin thickness (mm) 
at a challenge site (y axis). Challenge only, mean = 0.301 5 0.06 
mm, n = 20; unirradiated controls, mean = 3.05 t 0.043 mm. n = 
16; UVA II-irradiated, mean = 0.775 2 017 mm, n = 24. The 
response of the UVA 11-irradiated subjects differed significantly 
from that of the unirradiated control subjects, P < O.OOO1. 
the possibility of low and high susceptibility subsets that 
may correlate with skin cancer susceptibility ( 1  l), we also 
examined the data set for the presence of distinct groups, 
using a scatter plot (Fig. 2). The data for the unsensitized 
challenge group are also presented for comparison to the 
concurrently randomized positive control group (DNCB 
through normal skin) and the UVA I1 group. Whereas the 
mean irritant response to DNCB (challenge only) was 0.301 
2 0.006 mm, n = 20, the positive control group demonstrat- 
ed a mean response of 3.053 2 4.25 mm, with 93.8% pos- 
itive responses. By contrast, there were only 29.2% positive 
responses in the UVA II-irradiated, mean = 0.775 2 0.17 
mm, n = 24, P = 0.02. Although 2 of the 24 subjects ex- 
hibited a fully successful sensitization through UVA 11-ex- 
posed skin, it is not clear whether this percentage reflects a 
distinct subgroup cluster. 
Effect of UVA II on an immunization through a site 
distant to the UVA II exposure 
Each volunteer was sensitized on a matching site on the 
opposite (right) buttock with a second, noncross-reacting 
sensitizer (DPCP) to test for distant (systemic) effects of the 
UV radiation exposures. As for DNCB, the response to 
DPCP sensitization was measured by the mean increase in 
skin thickness (mm) at challenge sites (Fig. 3). The DPCP 
is less efficient at sensitizing than is DNCB, sensitizing few- 
er than 75% of the unirradiated volunteers in the groups 
being presented, yet the DPCP response was frequently 
stronger than the DNCB response, often resulting in blisters 
at the challenge sites, which made measurement difficult. 
The challenge doses of DPCP were adjusted downward in 
some of the groups during the study, in an attempt to alle- 
viate the blistering problem. Only the volunteers receiving 
the original dosages are included here, which explains the 
smaller numbers of volunteers shown. For the challenge only 
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Figure 3. Scattergram of DPCP responses in human subjects sen- 
sitized distant from UVA 11-exposed skin reveals distant immuno- 
suppression. The DPCP sensitization on the buttock opposite to the 
DNCB sensitization was measured by the mean increase in skin 
thickness (mm) at a challenge site (shown on the y axis). Concur- 
rently randomized challenge only negative controls, mean = 0.241 
-t 0.04 mm, n = 19; unirradiated positive controls, mean = 2.54 2 
0.36 mm, n = 36; UVA 11-irradiated subjects, mean = 3.15 2 0.89 
mm. n = 13. 
group, the mean skin fold thickness increase was 0.19 Ifr 
0.06 mm, n = 20; for the unirradiated controls, the mean 
skin fold thickness increase was 2.88 -C 0.41 mm, n = 38. 
The mean skin fold thickness increase was 3.15 ? 0.89 mm 
along the UVA 11-irradiated volunteers (n = 13). 
Toleragenic effects of UVA I1 
To determine whether sensitization on UVA 11-exposed skin 
induces tolerance to subsequent exposure to DNCB, individ- 
uals who did not respond to challenge after the initial sen- 
sitization (70.8%) were resensitized on normal skin 2 weeks 
to 5 months later. Of these individuals, 23.8% were again 
unresponsive to DNCB sensitization, whereas, among unir- 
radiated control individuals unresponsive to DNCB sensiti- 
zation (17%), only 3.8% were still negative after resensiti- 
zatibn on normal skin. This difference is significant, P = 
0.0006. 
Effects of UVA I1 radiation on HLA DR' epidermal cell 
subsets 
Ethidium monoazide-negative viable cells were selected, and 
from them cells staining intensely with APC-HLA-DR were 
gated and selected for further analysis (Fig. 5a,e). Both the 
unirradiated EC ( I )  and the UVA 11-irradiated EC (b) con- 
tained distinct populations of HLA-DR' cells. The EC 
stained with the isotype control contained only a negligible 
amount of background staining within the comparable areas 
(not shown). 
The HLA-DR + cells in unirradiated control epidermis 
were homogeneously CD1ah' CDl Ic'" (Fig. 5b), CD36- (Fig. 
5c) and CDllb-  (Fig. 5d). By contrast, UVA 11-irradiated 
epidermis contained a heterogeneous population of DR' 
cells. One population was represented by reduced LC 
(CDIah', CDI Icl", CD36- CDI lb-  cells in Fig. 5f circle F; 
5g box G; 5h box H). A second population could be iden- 
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Figure 4. DNCB sensitization through a UVA 11-exposure site caus- 
es decreased responsiveness and increased tolerance in 24% humans 
tested. The DNCB sensitization on UVA 11-exposed skin resulted in 
70.8% of individuals being unresponsive to challenge after the initial 
sensitization. These were then resensitized on normal skin. Of these 
individuals, 23.8% were again unresponsive to DNCB sensitization. 
By contrast, among individuals not receiving UVA I1 exposure yet 
unresponsive to initial DNCB sensitization (17%), only 3.8% were 
still negative after resensitization on normal skin. 
tified within an HLA-DR' CDI lchi non-LC population that 
was CDla- (Fig. 5f box I with 14.5% cells) relative to 0.0% 
cells that are DR+ CDllchi CDla- in control skin (Fig. 5b 
box L). In contrast to LC, which were CD36- CD1 Ib-, these 
HLA-DR' CD1 lchi cells in UVA 11-irradiated EC expressed 
macrophage markers and were thus CD36' (Fig. 5g circle 
J) and CDllb'  (Fig. 5h circle K). 
Data pertaining to the above cell populations (illustrated 
in Fig. 5) were pooled from multiple subjects (Table 1). The 
HLA-DR' portion of the viable EC was reduced by the ir- 
radiation from 1.5% of EC in the controls to 0.8% of EC in 
the UVA 11-treated group (P = 0.005). Among the HLA- 
DR+ cells, the CDla' cells were reduced by UVA I1 from 
90.1% of DR+ cells in controls to 75.0% of the lowered DR' 
cells within UVA 11-EC. The CDla' LC expressing CD36 
represented 0.8% of LC in control skin but rose to 11.1% 
of DR' cells in UVA 11-expressed skin. Within the expanded 
CDla- population, CD36' monocytic/macrophagic cells 
rose from <O.O% to 10.1%, bringing the total CD36' pop- 
ulation to 18 2 3% of DR' UVA 11-EC (not shown). Like- 
wise, CDl 1 b' monocytic/macrophagic cells increased from 
3.2% in DR' cells in controls to 23.7% of DR' cells in the 
UVA 11-treated group. The identities of the various subsets, 
as well as their quantitative relationships, are summarized in 
Fig. 6 as means of grouped data from multiple subjects. Each 
shared shading designation denotes a specific subset and 
whether it expresses the indicated marker (Fig. 6). 
DISCUSSION 
Ultraviolet A I1 has many biological activities in common 
with UVB. Ultraviolet A I1 is more biologically active than 
UVA I and highly relevant doses may be acquired during 
outdoor exposure as well as during tanning parlor exposure. 
Particularly high UVA I1 doses may occur when outdoor 
exposure times are increased due to the use of UVB-absorb- 
626 Gordon J. Levee et al. 
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Figure 5. Ultraviolet A I1 irradiation induces a population of macrophage-like CDla-,  CD36+, CDI Ib+ among the HLA-DR', CDI Ic' 
epidermal cells in human skin, similar to that induced by UVB. Four-color flow cytometric analysis shows contrasting patterns of cell 
phenotypes between UVA 11-irradiated and unirradiated control skin. Frames a and e show selection of HLA-DR+ cells in both groups. The 
HLA-DR' cells were then analyzed for CDI Ic, CDla, CD36 and CDI Ib. Frame b (unirradiated control skin) shows a distinct population 
of CDla' cells (gate B) but no CDla- cells (gate L) among the CDI Ic' cells. In UVA 11-irradiated skin (frame f), with the same selection, 
CDla+ cells are reduced in number (gate F) and there is a small, strongly CDla-, CDI lchi population seen (gate I). There are insignificant 
numbers of CD36' cells (frame c, gate M) and CDllb' cells (frame d, gate N) in the unirradiated controls; however, the UVA 11-irradiated 
cells clearly show the presence of both CD36 (frame g, gate J) and CDI lb  (frame h, gate K), both of which are CDl lchi. 
ing sunscreens. In addition, because UVA I1 intensity at the 
earth's surface is attenuated by stratospheric ozone, especial- 
ly those wavelengths in the shorter, more energetic portion 
of this waveband, ozone depletion is predicted to result in 
increased biologic activity of UVA I1 wavelengths reaching 
the earth (45). The ability of UVA photons to alter the dose- 
response relationship of UVB on EC (46), and the active 
role of UVA II in photocarcinogenesis (47-50), in immu- 
nologic alteration ( 15,17,19,20,37,5 1,52) and in processes 
active in photoaging (18,33,39,40,53-55) makes it impera- 
tive to understand the actions of UVA II in human skin in 
vivo. 
We report here that UVA II has immunologic effects on 
human skin, which exhibit a distinctive pattern that shares 
some features with UVB exposure effects and some features 
with UVA I exposure effects. The human skin immunologic 
response to UVA 11 is similar to UVB in that there is: (a) a 
reduced ability to support contact sensitization; (b) a capac- 
ity to induce active suppression of DNCB responsiveness 
(tolerance); (c) a reduction in the number of LC (phenotype: 
Table 1. 
CDI Ib 
UVA 11* depletes CDla' DR' LC but concomitantly induces minor populations of CDla- DR' cells expressing CD36 and/or 
% of DR' 
% of EC CDla' CDla- CD36' 
Waveband HLA-DR' CD I a+ CD36' CD36' CDI Ib' CDI Ib' 
Control 1.5 t 0.3t 90.1 2 1.4$ 0.8 2 0.50s 0.0 2 0.05 0.2 2 0.21 3.2 2 1.1$ 
UVA I1 0.8 t 0.1 75.0 2 4.2 11.1 t 6.9 10.1 2 6.1 8.6 2 1.9 23.7 t 8.7 
*All skin was tested 3 days after 4 MED UV irradiation. 
tPercentage of total (viable) epidermal cells expressing the indicated phenotype (mean of n = 22, -CSEM). 
$Percentage of DR' cells expressing the indicated phenotype (mean of n = 10, ZSEM). 
§Percentage of DR' cells expressing the indicated phenotype (mean of n = 4, ZSEM). 
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Figure 6. Proportional relationships 
of HLA-DR' subsets in epidermis 
from normal (a) and UVA-I1 (b)-ex- 
posed skin. Data expressed as % of 
total EC for HLA-DR-expressing 
cells (top panels) or as % of HLA- 
DR' EC for cells expressing CDla ,  
CD36 or CDI Ib. From triple color 
analysis, cell populations are shown 
as distinct bar shadings to indicate 
subsets of the following phenotypes: 
1 )  CDla '  CD36- C D l l b -  DR'; 
2) CDla '  CD36' C D l l b -  DR'; 
3) CDla -  CD36' C D l l b '  DR'; 
4) CDla  CD36 CDI Ib' DR'. 
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CDla' DR+ CD36- CDl lb-) and, (d) epidermal infiltration 
with cells of macrophagic phenotype (CDla- DR' CD36' 
CDI lb+). Ultraviolet A I1 differs from UVB in that it in- 
duces the appearance of a minor population of LC with a 
unique phenotype: CDla' DR+ CD36' CDl lb' and results 
in a less potent depleting effect on CDla' DR' LC than 
does UVB. 
It is not clear at this point whether the immunosuppressive 
effects of UVA I1 on contact sensitization induction in hu- 
man subjects is due predominantly to the UVB-like effects 
or to the UVA-like effects. Ultraviolet A I1 is considered to 
contain both UVB and UVA I photons and the biologic ac- 
tivity of this waveband may be the result of a balanced or 
combinatorial effect of both types of photons, without an 
overwhelming dominance of one over the other (3836). 
Thus, study of this waveband may actually reflect the bal- 
ance of processes that occur in response to the more intense 
mix of UVA I and UVB photons that occur in natural sun- 
light. 
The dose of UVA I1 used in the current study, 4 MED, 
resulted in a highly suppressed immune response to DNCB 
in 90% of the subjects tested (Fig. 2). This effect is at least 
as, and possibly more suppressive than an equally erythemo- 
genic single dose of UVB (Fig. l), after which only about 
60% of subjects are highly suppressed using fluorescent sun- 
Altered immunization in vivo is likely related to the 
changes observed in antigen-presenting cell composition of 
the epidermis after UVA I1 exposure. Ultraviolet A I1 clearly 
reduced LC density to levels comparable to similar doses of 
UVA and UVB. Ultraviolet A I and UVB both reduce LC 
density (57,58), but UVA I results in only a very transient 
inhibition of LC functional activity, with extremely rapid 
recovery (30). Because LC that have newly repopulated the 
epidermis or in atopic dermatitis skin can doubly express 
CDla and CD36 (59.60) and normal human LC in the der- 
mis can doubly express CDla and CD1 l b  (42), it is possible 
that the novel population of CDla' cells expressing CD36 
and CD1 l b  in UVA I1 skin are repopulating immigrants 
from the dermis or blood (Fig. 4) (Table 1) (Fig. 6, double 
diagonal cross hashes). 
With regard to macrophage infiltration (Table 1) (Fig. 6, 
double vertical horizontal cross hashes and single wide di- 
agonal hashes) the degree of infiltration is markedly less 
after UVA 11 exposure ([ 10.1 % CD36+ CD la- cells among 
DR' UVA I1 EC] X [0.8% DR+ cells among total UVA I1 
lamps (12). 
UVA I 1  t320-340nm) 
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CDla' 
EC] = 0.08% of all UVA II EC that are macrophagic cells) 
(Table 1) than after UVB exposure (3-15% of all UVB EC 
that are macrophagic cells) (24.61) and in the same range as 
after UVA I exposure ([33% CD36' among DR' UVA I 
EC] X [0.3% DR' among total UVA] = 0.1% of all UVA 
I EC that are macrophagic cells) (16). Whether these epi- 
dermal changes are reflected in the dermis, as they are after 
UVB (61), remains to be determined but may be a critical 
element dictating the outcome of immunization through 
UVA 11-exposed skin. 
In summary UVA 11, the shorter wavelength, more ener- 
getic component of the UVA waveband, is clearly immu- 
nosuppressive. Its unique features of LC depletion with in- 
duction of LC of novel phenotype and without a high degree 
of macrophagic induction is more reminiscent of UVA I than 
UVB. In distinction to UVA I, however, UVA I1 induced 
tolerance to the contact sensitization, whereas murine UVA 
I studies have indicated an inability of UVA I to induce 
tolerance, despite LC depletion (19,20). These findings in- 
dicate that conditions of increased UVA I1 exposure, such 
as during prolonged outdoor exposure under sunscreen, or 
tanning parlor exposure or exposure to stratospheric ozone- 
depleted solar radiation, will result in cutaneous immuno- 
suppression to normally immunogenic agents introduced 
through the exposed skin. 
We report here that a single erythemagenic exposure to 
UVA I1 can reduce the immunization rate and induce tol- 
erance to a potent immunogen such as DNCB. The appear- 
ance of complex mixtures of cells with antigen-presenting 
cell potential in the UVA II-exposed epidermis is further 
evidence that UVA II, although distinct in certain aspects 
from UVB, shares critical immunosuppressive activities with 
UVB. 
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